Literature DB >> 3016161

Characterization of cells transformed by the human polyomavirus JC virus.

C W Mandl, R J Frisque.   

Abstract

One unique feature of the prototype JC virus (JCV) (Mad 1) genome is the occurrence of a second TATA sequence within the early promoter region. A naturally occurring oncogenic variant of JCV (Mad 4) lacks this second TATA box. Several cell lines transformed by Mad 1, Mad 4 and simian virus 40 were characterized, in part to investigate whether the second TATA sequence is functional. S1 nuclease mapping of early JCV gene transcription products revealed a major set of start sites common to both Mad 1 and Mad 4 mRNAs. In addition, a second set of early transcripts was found exclusively in Mad 1 transformants, presumably positioned by the second TATA box. The presence of these unique mRNAs in the Mad 1-transformed cells did not appear to have any bearing on the other parameters investigated, including size and quantity of early viral proteins, integration patterns of viral DNA and growth properties of the cells.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3016161     DOI: 10.1099/0022-1317-67-8-1733

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  10 in total

1.  Detection of JC virus DNA sequence and expression of the viral oncoprotein, tumor antigen, in brain of immunocompetent patient with oligoastrocytoma.

Authors:  A Rencic; J Gordon; J Otte; M Curtis; A Kovatich; P Zoltick; K Khalili; D Andrews
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-09       Impact factor: 11.205

2.  Analysis of capsid formation of human polyomavirus JC (Tokyo-1 strain) by a eukaryotic expression system: splicing of late RNAs, translation and nuclear transport of major capsid protein VP1, and capsid assembly.

Authors:  Y Shishido-Hara; Y Hara; T Larson; K Yasui; K Nagashima; G L Stoner
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

3.  Construction and characterization of hybrid polyomavirus genomes.

Authors:  W F Chuke; D L Walker; L B Peitzman; R J Frisque
Journal:  J Virol       Date:  1986-12       Impact factor: 5.103

4.  Derivation and characterization of POJ cells, transformed human fetal glial cells that retain their permissivity for JC virus.

Authors:  C Mandl; D L Walker; R J Frisque
Journal:  J Virol       Date:  1987-03       Impact factor: 5.103

5.  Detection of human JCPyV and BKPyV in diffuse large B-cell lymphoma of the GI tract.

Authors:  C E Tseng; C M Yeh; C Y Fang; J Shay; P L Chen; M C Lin; D Chang; M Wang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-11-21       Impact factor: 3.267

6.  A comparison of BKV, JCV, and SV 40 transcriptional enhancers in primate cells. Application of the two-phase partition assay for chloramphenicol acetyl transferase (CAT).

Authors:  J D Martin
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

Review 7.  Molecular biology, epidemiology, and pathogenesis of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain.

Authors:  Michael W Ferenczy; Leslie J Marshall; Christian D S Nelson; Walter J Atwood; Avindra Nath; Kamel Khalili; Eugene O Major
Journal:  Clin Microbiol Rev       Date:  2012-07       Impact factor: 26.132

8.  Detection of JC virus DNA sequences in colorectal cancers in Japan.

Authors:  Ryouta Hori; Yoshihiro Murai; Kouichi Tsuneyama; Hekmat Osman Abdel-Aziz; Kazuhiro Nomoto; Hiroyuki Takahashi; Chun-mei Cheng; Tomohiko Kuchina; Brian V Harman; Yasuo Takano
Journal:  Virchows Arch       Date:  2005-10-19       Impact factor: 4.064

9.  Mad-1 is the exclusive JC virus strain present in the human colon, and its transcriptional control region has a deleted 98-base-pair sequence in colon cancer tissues.

Authors:  L Ricciardiello; D K Chang; L Laghi; A Goel; C L Chang; C R Boland
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

Review 10.  Pathogenesis and molecular biology of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain.

Authors:  E O Major; K Amemiya; C S Tornatore; S A Houff; J R Berger
Journal:  Clin Microbiol Rev       Date:  1992-01       Impact factor: 26.132

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.